Inovio announces 1-for-4 reverse split

|About: Inovio Pharmaceuticals, Inc. (INO)|By:, SA News Editor

Inovio Pharmaceuticals' (INO -4.5%) board approves a one-for-four reverse split of the company's common stock.

The announcement comes ahead of expected mid-2014 phase-2 clinical data on INO's lead pipeline asset VGX-3100, a therapeutic vaccine to treat cervical intraepithelial neoplasia.